BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27340772)

  • 21. [Genotyping of viral glycoprotein B (gB) in hematopoietic stem cell transplant recipients with active cytomegalovirus infection: analysis of the impact of gB genotypes on the patients' outcome].
    Roubalová K; Strunecký O; Zufanová S; Procházka B; Vitek A
    Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):92-9. PubMed ID: 20586171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies.
    Khawaja F; Chemaly RF
    Haematologica; 2019 Jul; 104(7):1322-1331. PubMed ID: 31221784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications.
    Bonadio M; Morelli G; Mori S; Riccioni R; Papineschi F; Petrini M
    Biomed Pharmacother; 2005 Oct; 59(9):511-6. PubMed ID: 16274955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viremic co-infections in children with allogeneic haematopoietic stem cell transplantation are predominated by human polyomaviruses.
    Koskenvuo M; Rahiala J; Sadeghi M; Waris M; Vuorinen T; Lappalainen M; Norja P; Toppinen M; Saarinen-Pihkala U; Allander T; Söderlund-Venermo M; Hedman K; Ruuskanen O; Vettenranta K
    Infect Dis (Lond); 2017 Jan; 49(1):35-41. PubMed ID: 27465580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Surveillance of cytomegalovirus for antiviral efficacy and risk factors in allogeneic hematopoietic stem cell transplantation].
    Jia JS; Liu DP; Huang XJ; Wu T; Liu DH; Zhang YC; Su H; Wang JB; Zhou JR; Liu Q; Ying MY; Sun RJ; Duan X; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):749-54. PubMed ID: 16928314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HHV-6 infection after allogeneic hematopoietic stem cell transplantation: From chromosomal integration to viral co-infections and T-cell reconstitution patterns.
    Quintela A; Escuret V; Roux S; Bonnafous P; Gilis L; Barraco F; Labussière-Wallet H; Duscastelle-Leprêtre S; Nicolini FE; Thomas X; Chidiac C; Ferry T; Frobert E; Morisset S; Poitevin-Later F; Monneret G; Michallet M; Ader F;
    J Infect; 2016 Feb; 72(2):214-22. PubMed ID: 26518057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation.
    Almyroudis NG; Jakubowski A; Jaffe D; Sepkowitz K; Pamer E; O'Reilly RJ; Papanicolaou GA
    Transpl Infect Dis; 2007 Dec; 9(4):286-94. PubMed ID: 17511819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytomegalovirus glycoprotein B genotype in hematopoietic stem cell transplant patients from China.
    Wu X; Wang Y; Xu Y; Wu D; Sun A; Zhu Z; Han Y; Qiu H; Tang X; Fu Z; He G; Li C; Ma X; Liu Y
    Biol Blood Marrow Transplant; 2010 May; 16(5):647-52. PubMed ID: 20025986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Respiratory virus infection after allogeneic hematopoietic stem cell transplant in a tropical center: Predictive value of the immunodeficiency scoring index.
    Wang L; Allen J; Diong C; Goh YT; Gopalakrishnan S; Ho A; Hwang W; Lim F; Oon L; Tan TT; Linn YC; Tan BH
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28295964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous Quantification of the 8 Human Herpesviruses in Allogeneic Hematopoietic Stem Cell Transplantation.
    Gomes de Oliveira PG; Ueda MY; Real JM; de Sá Moreira E; Rodrigues de Oliveira JS; Gonçalves MV; Ginani VC; de Oliveira Felix OM; Seber A; Novis Y; Rocha V; Granato CF; Arrais-Rodrigues C
    Transplantation; 2016 Jun; 100(6):1363-70. PubMed ID: 26555946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
    George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
    Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of respiratory viral coinfection and cytomegalovirus coisolation in pediatric inpatients.
    Fuller DG; Davie G; Lamb D; Carlin JB; Curtis N
    Pediatr Infect Dis J; 2005 Mar; 24(3):195-200. PubMed ID: 15750453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does respiratory virus coinfection increases the clinical severity of acute respiratory infection among children infected with respiratory syncytial virus?
    Harada Y; Kinoshita F; Yoshida LM; Minh le N; Suzuki M; Morimoto K; Toku Y; Tomimasu K; Moriuchi H; Ariyoshi K
    Pediatr Infect Dis J; 2013 May; 32(5):441-5. PubMed ID: 23838658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is cytomegalovirus testing of blood products still needed for hematopoietic stem cell transplant recipients in the era of universal leukoreduction?
    Kekre N; Tokessy M; Mallick R; McDiarmid S; Huebsch L; Bredeson C; Allan D; Tay J; Tinmouth A; Sheppard D
    Biol Blood Marrow Transplant; 2013 Dec; 19(12):1719-24. PubMed ID: 24099958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic utility of human cytomegalovirus-specific T-cell response monitoring in predicting viremia in pediatric allogeneic stem-cell transplant patients.
    Abate D; Cesaro S; Cofano S; Fiscon M; Saldan A; Varotto S; Mengoli C; Pillon M; Calore E; Biasolo MA; Cusinato R; Barzon L; Messina C; Carli M; Palù G
    Transplantation; 2012 Mar; 93(5):536-42. PubMed ID: 22314338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pretransplantation respiratory syncytial virus infection: impact of a strategy to delay transplantation.
    Peck AJ; Corey L; Boeckh M
    Clin Infect Dis; 2004 Sep; 39(5):673-80. PubMed ID: 15356782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of post-treatment viral load of cytomegalovirus in patients with hematologic malignancies.
    Lu W; Chen HP; Chan YJ; Wang FD
    J Microbiol Immunol Infect; 2021 Apr; 54(2):245-252. PubMed ID: 31444112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytomegalovirus (CMV) infections in children undergoing hematopoetic stem cell transplantation.
    Zaucha-Prazmo A; Wójcik B; Drabko K; Choma M; Kowalczyk JR
    Pediatr Hematol Oncol; 2005 Jun; 22(4):271-6. PubMed ID: 16020113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upper respiratory viral infections in patients with haematological malignancies after allogeneic haematopoietic stem cell transplantation: a retrospective study.
    Atilla E; Sahin D; Atilla PA; Dolapci I; Tekeli A; Bozdag SC; Yuksel MK; Toprak SK; Ilhan O; Arslan O; Ozcan M; Gurman G; Topcuoglu P
    Antivir Ther; 2018; 23(6):523-527. PubMed ID: 29424696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.